Citation

Bravo EA, Carrion L, Paucar SM, Mendoza R, Rivera C. Dermatol. Online J. 2014; 20(4).

Copyright

(Copyright © 2014, University of California at Davis)

DOI

unavailable

PMID

unavailable

Abstract

Pityriasis Rubra Pilaris (PRP) is an uncommon skin disorder characterized by follicular keratosis, palmoplantar keratoderma, and erythroderma. The traditional preferred treatment is oral retinoids, but over the last decade, biologic therapy with anti- TNF agents has been used with success. We report the case of a 51 year- old man with a clinical and histopathological diagnosis of PRP. He underwent therapy with adalimumab and showed clearance of skin lesions within the fourth week of treatment.

Language: en

Keywords

Humans; Male; Middle Aged; adult; human; male; case report; suicide attempt; article; human tissue; physical examination; middle aged; pathology; drug withdrawal; antihistaminic agent; corticosteroid; erythema; pruritus; urea; histopathology; gout; tumor necrosis factor alpha; prostate hypertrophy; skin; etretin; Dermatologic Agents; dermatological agent; outcome assessment; treatment duration; drug substitution; adalimumab; monoclonal antibody; Tumor Necrosis Factor-alpha; Skin; antagonists and inhibitors; parakeratosis; Adalimumab; skin redness; erythroderma; Antibodies, Monoclonal, Humanized; acanthosis; palmoplantar keratoderma; petrolatum; pityriasis rubra pilaris; Pityriasis rubra pilaris; Pityriasis Rubra Pilaris